These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 12647987

  • 21. Synthesis and ribonucleotide reductase inhibitory activity of analogues of 2,3-dihydro-1H-imidazo[1,2-b]pyrazole (IMPY).
    Goddard AJ, Orr RM, Stock JA, Wilman DE.
    Anticancer Drug Des; 1987 Dec; 2(3):235-45. PubMed ID: 3329526
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Inhibition of ribonucleotide reductase by caracemide.
    Moore EC, Loo TL.
    Cancer Treat Rep; 1984 Oct; 68(10):1293-4. PubMed ID: 6395952
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. New advances in the treatment of hematologic malignancies: focus on topoisomerase I inhibitors. Introduction.
    Kantarjian H.
    Semin Hematol; 1998 Jul; 35(3 Suppl 4):1-2. PubMed ID: 9779875
    [No Abstract] [Full Text] [Related]

  • 29. Ribonucleotide reductase inhibitors and future drug design.
    Shao J, Zhou B, Chu B, Yen Y.
    Curr Cancer Drug Targets; 2006 Aug; 6(5):409-31. PubMed ID: 16918309
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present.
    Huff SE, Winter JM, Dealwis CG.
    Biomolecules; 2022 Jun 10; 12(6):. PubMed ID: 35740940
    [Abstract] [Full Text] [Related]

  • 34. Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity.
    Finch RA, Liu MC, Cory AH, Cory JG, Sartorelli AC.
    Adv Enzyme Regul; 1999 Jun 10; 39():3-12. PubMed ID: 10470363
    [Abstract] [Full Text] [Related]

  • 35. Antitumor activity of 2,2'-bipyridyl-6-carbothioamide: a ribonucleotide reductase inhibitor.
    Nocentini G, Barzi A.
    Gen Pharmacol; 1997 Nov 10; 29(5):701-6. PubMed ID: 9347313
    [Abstract] [Full Text] [Related]

  • 36. Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazones.
    Cory JG, Cory AH, Rappa G, Lorico A, Liu MC, Lin TS, Sartorelli AC.
    Biochem Pharmacol; 1994 Jul 19; 48(2):335-44. PubMed ID: 8053929
    [Abstract] [Full Text] [Related]

  • 37. Effect on ribonucleotide reductase of novel lipophilic iron chelators: the desferri-exochelins.
    Hodges YK, Antholine WE, Horwitz LD.
    Biochem Biophys Res Commun; 2004 Mar 12; 315(3):595-8. PubMed ID: 14975742
    [Abstract] [Full Text] [Related]

  • 38. DNA-protective activity of new ribonucleotide reductase inhibitors.
    Rauko P, Romanova D, Miadokova E, Macakova K, Novotny L, Elford HL, Szekeres T.
    Anticancer Res; 1997 Mar 12; 17(5A):3437-40. PubMed ID: 9413183
    [Abstract] [Full Text] [Related]

  • 39. Ribonucleotide reductase inhibitors as anticancer and antiviral agents.
    Lien EJ.
    Prog Drug Res; 1987 Mar 12; 31():101-26. PubMed ID: 3326028
    [No Abstract] [Full Text] [Related]

  • 40. Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells.
    Myette MS, Elford HL, Chitambar CR.
    Cancer Lett; 1998 Jul 17; 129(2):199-204. PubMed ID: 9719462
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.